Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis

American Journal of Pathology

Volumn 166, Issue 1, 2005, Pages 73-80

  Oh, Bong Kyeong ^a   Kim, Young Joo ^a   Park, Chanil ^a   Young, Nyun Park ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN; TELOMERE BINDING PROTEIN; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 1 INTERACTING NUCLEAR PROTEIN 2; TELOMERIC REPEAT BINDING FACTOR 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER CARCINOGENESIS; LIVER CIRRHOSIS; LIVER REGENERATION; MALE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STATISTICAL SIGNIFICANCE; TELOMERE; TRANSCRIPTION INITIATION; UPREGULATION;

EID: 11144227269     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62233-X     Document Type: Article

References (40)

1. Wright JH, Gottschling DE, Zakian VA: Saccharomyces telomeres assume a non-nucleosomal chromatin structure. Genes Dev 1992, 6:197-210
2. Tommerup H, Dousmanis A, de Lange T: Unusual chromatin in human telomeres. Mol Cell Biol 1994, 14:5777-5785
3. Nugent CI, Hughes TR, Lue NF, Lundblad V: Cdc13p: a single-strand telomeric DNA-binding protein with a dual role in yeast telomere maintenance. Science 1996, 274:249-252
4. Karlseder J: Telomere repeat binding factors: keeping the ends in check. Cancer Lett 2003, 194:189-197
5. Collins K: Mammalian telomeres and telomerase. Curr Opin Cell Biol 2000, 12:378-383
6. Blackburn EH: Switching and signaling at the telomere. Cell 2001, 106:661-673
7. Kim SH, Kaminker P, Campisi J: Telomeres, aging and cancer: in search of a happy ending. Oncogene 2002, 21:503-511
8. Hackett JA, Greider CW: Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Oncogene 2002, 21:619-626
9. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, de Lange T: Mammalian telomeres end in a large duplex loop. Cell 1999, 97:503-514
10. Stansel RM, de Lange T, Griffith JD: T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J 2001, 20:5532-5540
11. van Steensel B, de Lange T: Control of telomere length by the human telomeric protein TRF1. Nature 1997, 385:740-743
12. Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schaefer MR, Schnapp G, de Lange T: Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 2000, 20:1659-1668
13. van Steensel B, Smogorzewska A, de Lange T: TRF2 protects human telomeres from end-to-end fusions. Cell 1998, 92:401-413
14. Kim SH, Kaminker P, Campisi J: TIN2, a new regulator of telomere length in human cells. Nat Genet 1999, 23:405-412
15. Smith S, Giriat I, Schmitt A, de Lange T: Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 1998, 282:1484-1487
16. Li B, Oestreich S, de Lange T: Identification of human Rap1: implications for telomere evolution. Cell 2000, 101:471-483
17. Nakanishi K, Kawai T, Kumaki F, Hiroi S, Mukai M, Ikeda E, Koering CE, Gilson E: Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Clin Cancer Res 2003, 9:1105-1111
18. Miyachi K, Fujita M, Tanaka N, Sasaki K, Sunagawa M: Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer. J Exp Clin Cancer Res 2002, 21:269-275
19. Klapper W, Krams M, Qian W, Janssen D, Parwaresch R: Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation. Br J Cancer 2003, 89:713-719
20. Saito K, Yagihashi A, Nasu S, Izawa Y, Nakamura M, Kobayashi D, Tsuji N, Watanabe N: Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer. Jpn J Cancer Res 2002, 93:253-258
21. Yamada M, Tsuji N, Nakamura M, Moriai R, Kobayashi D, Yagihashi A, Watanabe N: Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers. Anticancer Res 2002, 22:3303-3307
22. Yamada K, Yagihashi A, Yamada M, Asanuma K, Moriai R, Kobayashi D, Tsuji N, Watanabe N: Decreased gene expression for telomeric-repeat binding factors and TIN2 in malignant hematopoietic cells. Anticancer Res 2002, 22:1315-1320
23. International Working Party: Terminology of nodular hepatocellular lesions. Hepatology 1995, 22:983-993
24. Miura N, Horikawa I, Nishimoto A, Ohmura H, Ito H, Hirohashi S, Shay JW, Oshimura M: Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet 1997, 93:56-62
25. Huang GT, Lee HS, Chen CH, Chiou LL, Lin YW, Lee CZ, Chen DS, Sheu JC: Telomerase activity and telomere length in human hepatocellular carcinoma. Eur J Cancer 1998, 34:1946-1949
26. Hytiroglou P, Kotoula V, Thung SN, Tsokos M, Fiel MI, Papadimitriou CS: Telomerase activity in precancerous hepatic nodules. Cancer 1998, 82:1831-1838
27. Kitamoto M, Ide T: Telomerase activity in precancerous hepatic nodules. Cancer 1999, 85:245-248
28. Isokawa O, Suda T, Aoyagi Y, Kawai H, Yokota T, Takahashi T, Tsukada K, Shimizu T, Mori S, Abe Y, Suzuki Y, Nomoto M, Mita Y, Yanagi M, Igarashi H, Asakura H: Reduction of telomeric repeats as a possible predictor for development of hepatocellular carcinoma: convenient evaluation by slot-blot analysis. Hepatology 1999, 30: 408-412
29. Youssef N, Paradis V, Ferlicot S, Bedossa P: In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis. J Pathol 2001, 194:459-465
30. Oh BK, Chae KJ, Park C, Kim K, Lee WJ, Han KH, Park YN: Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis. J Hepatol 2003, 39:786-792
31. Oh BK, Seong JK, Lee JE, Chae KJ, Roh KJ, Park C, Park YN: Induction of telomerase activity during an early burst of proliferation in pancreatic regeneration. Cancer Lett 2002, 186:93-98
32. Kruk PA, Rampino NJ, Bohr VA: DNA damage and repair in telomeres: relation to aging. Proc Natl Acad Sci USA 1995, 92:258-262
33. Igarashi M, Suda T, Hara H, Takimoto M, Nomoto M, Takahashi T, Okoshi S, Kawai H, Mita Y, Waguri N, Aoyagi Y: Interferon can block telomere erosion and in rare cases result in hepatocellular carcinoma development with telomeric repeat binding factor 1 overexpression in chronic hepatitis C. Clin Cancer Res 2003, 9:5264-5270
34. Ancelin K, Brunori M, Bauwens S, Koering CE, Brun C, Ricoul M, Pommier JP, Sabatier L, Gilson E: Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2. Mol Cell Biol 2002, 22:3474-3487
35. Kim SH, Han S, You YH, Chen DJ, Campisi J: The human telomere-associated protein TIN2 stimulates interactions between telomeric DNA tracts in vitro. EMBO Rep 2003, 4:685-691
36. Ancelin K, Brun C, Gilson E: Role of the telomeric DNA-binding protein TRF2 in the stability of human chromosome ends. Bioessays 1998, 20:879-883
37. Karlseder J, Smogorzewska A, de Lange T: Senescence induced by altered telomere state, not telomere loss. Science 2002, 295:2446-2449
38. Theise ND, Park YN, Kojiro M: Dysplastic nodules and hepatocarcinogenesis. Clinical Liver Disease. Liver Histopathology. Edited by JH Lefkowitch. Philadelphia, W.B. Saunders, 2002, pp 497-512
39. Ishikawa F: Breakthrough and views. Telomere crisis, the driving force in cancer cell evolution. Biochem Biophys Res Commun 1997, 230:1-6
40. Nishida N, Nishimura T, Ito T, Komeda T, Fukuda Y, Nakano K: Chromosomal instability and human hepatocarcinogenesis. Histol Histopathol 2003, 18:897-909